News Acacia Pharma stock market launch to support nausea products Acacia Pharma is to raise new funds through an initial global offering and launch on to the Euronext Brussels stock exchange
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
